| Zacks Company Profile for Medtronic PLC (MDT : NYSE) |
|
|
| |
| • Company Description |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Number of Employees: 95,000 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $94.17 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 8,008,927 shares |
| Shares Outstanding: 1,279.14 (millions) |
| Market Capitalization: $120,456.41 (millions) |
| Beta: 0.56 |
| 52 Week High: $106.33 |
| 52 Week Low: $73.31 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
8.04% |
8.59% |
| 12 Week |
17.42% |
13.05% |
| Year To Date |
-1.97% |
-13.06% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Geoffrey S. Martha - Chairman and Chief Executive Officer
Thierry Pieton - Executive Vice President and Chief Financial Offic
Denise L. Blomquist - Vice President and Chief Accounting Officer
Michelle Quinn - Executive Vice President; General Counsel and Secr
Craig Arnold - Director
|
|
Peer Information
Medtronic PLC (BJCT)
Medtronic PLC (CADMQ)
Medtronic PLC (APNO)
Medtronic PLC (UPDC)
Medtronic PLC (IMTIQ)
Medtronic PLC (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: G5960L103
SIC: 3845
|
|
Fiscal Year
Fiscal Year End: April
Last Reported Quarter: 07/01/26
Next Expected EPS Date: 11/17/26
|
|
Share - Related Items
Shares Outstanding: 1,279.14
Most Recent Split Date: 9.00 (2.00:1)
Beta: 0.56
Market Capitalization: $120,456.41 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 3.06% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.34 |
Indicated Annual Dividend: $2.88 |
| Current Fiscal Year EPS Consensus Estimate: $5.96 |
Payout Ratio: 0.50 |
| Number of Estimates in the Fiscal Year Consensus: 12.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: 7.15% |
Last Dividend Paid: 06/26/2026 - $0.72 |
| Next EPS Report Date: 11/17/26 |
|
|
|
| |
